Lonza, which has been expanding its cell manufacturing operation but still faces challenges in other parts of its business, will have to face those with a new CEO. Marc Funk is leaving after less than a year in the top job.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,